Ruesch_Drip1_100920v3

To view this email as a web page, click here.

Bristol Myers Squibb cordially invites you to participate in a promotional program:

A Treatment Option for Patients with Myelofibrosis

Wednesday, July 27, 2021 • 7:00pm - 8:00pm EDT

Objectives:

Clinical data supporting a treatment option for patients with intermediate-2 or high-risk myelofibrosis
NCCN Clinical Practice Guidelines surrounding use of the treatment option in myelofibrosis
Safety, adverse event management, and dose modifications
Steps for starting your patients on this treatment option

Expert insights provided by:

Amit A Patel, MD, AACP

Hudson Hematology Oncology, LLC
American Infusion Center, LLC
Jersey City, NJ 07302
Hematology/Oncology
Diplomate, American Board of Internal Medicine
Vice President, Medical-Dental Staff, RWJ Barnabas Health - Jersey City Medical Center
Chairman, Credentials Committee, RWJ Barnabas Health - Jersey City Medical Center
Associate Editor, Hematology & Transfusion International Journal
Associate Professor of Medicine, St George's University School of Medicine
Clinical Assistant Professor of Medicine, RWJ Barnabas Health - Jersey City Medical Center
Clinical Assistant Professor of Medicine, New York Institute of Technology

Pursuant to the PhRMA Code on Interactions with Healthcare Professionals, attendance at this webcast program is restricted to U.S. healthcare professionals.

Bristol Myers Squibb will report transfers of value made to U.S.healthcare professionals to the extent required by federal and state laws, as applicable. To learn more about how Bristol Myers Squibb complies with the U.S. Physician Payments Sunshine Act visit https://www.bms.com/about-us/responsibility/position-on-keyissues/
transparency/global-interactions-with-healthcareprofessionals/the-physician-paymentsunshine-act-ppsa.html

This is a promotional program and no CME credits are offered.

Intended for specific recipient only, please do not forward or further disseminate.
© 2021 Bristol-Myers Squibb Company.
HE-US-2100140 07/21

Learn more about MJH Live Sciences products, partnerships, and solutions by visiting our website at https://www.mjhlifesciences.com/